RESULTS: Within the 2012 MarketScan® database, a total of 11,042 individuals with sarcoidosis were identified. Every US state was represented in the data with higher numbers of observations from the South Eastern states. A majority were female (59%), mean age was 49.3 years (SD 9.8). Of these, 1,792 (16.2%) had one or more hospital admissions (mean1.6 SD 1.3) during 2012 resulting in a mean of 8.1 hospital days (SD 14.5) used during the year for those patients with admissions. Prednisone was the most commonly prescribed medication with 25.5% use. Use of methotrexate was 2.7%, with 210 (1.9%) of patients on both prednisone and methotrexate. Use of hydroxychloroquine was 4.0%, azathioprine 1.2%, and biologics 0.6%. Prednisone doses ranged from 1-50mg per day, with a mean of 15mg/day (SD 8.1). The majority of patients (47%) received 20mg, and 36% received 10mg per day. Duration of prednisone use varied, with 39% filling prescriptions for less than 30 days, 42% receiving prednisone for 1 to 6 months and 19% having more than 6 months of use.